INTRODUCTION
Dihydrodipicolinate synthase (DHDPS) (EC 4.3.3.7) is an allosteric enzyme that catalyzes the first committed step in the lysine biosynthesis pathway of bacteria and plants (Dogovski et al., 2009 (Dogovski et al., , 2012 Soares da Costa et al., 2015) (Figure 1 ). This pathway produces key building blocks for the synthesis of housekeeping proteins, virulence factors, and the peptidoglycan cell wall in bacteria (Dogovski et al., 2009 (Dogovski et al., , 2012 Soares da Costa et al., 2015) . It is therefore not surprising that DHDPS is the product of an essential bacterial gene (Becker et al., 2006; Dogovski et al., 2013; Forsyth et al., 2002; Kobayashi et al., 2003) . Given its essentiality to pathogenic bacteria and absence in humans, DHDPS is considered a promising antibiotic target (Hutton et al., 2007) . This has generated considerable interest in characterizing the structure, function, and inhibition of this bacterial enzyme.
DHDPS exists as dimers or tetramers with the dimeric unit containing all the molecular requirements for catalysis and allostery Mirwaldt et al., 1995) . However, tetramers are more commonly observed in both Gram-negative and Gram-positive bacteria, most likely because tetramerization stabilizes conformational dynamics to afford optimal enzymatic function (Griffin et al., 2008 Voss et al., 2010) . By contrast, dimeric forms of DHDPS have evolved to stabilize dynamics by increasing the buried surface area at the dimeric interface (Burgess et al., 2008a) .
Functionally, DHDPS catalyzes the condensation of pyruvate and (S)-aspartate semialdehyde (ASA) to form the heterocyclic product, hydroxytetrahydrodipicolinic acid ( Figure 1 ). Not surprisingly, traditional DHDPS inhibition strategies have focused on developing small molecules with analogy to these substrates and/or products (Boughton et al., 2008; Hutton et al., 2003 Hutton et al., , 2007 Laber et al., 1992; Mitsakos et al., 2008; Turner et al., 2005a Turner et al., , 2005b . The most potent substrate-analog inhibitor discovered to date is dipicolinic acid N-oxide, which has a half-maximal inhibitory concentration (IC 50 ) value of 0.8 mM (Couper et al., 1994) . The DHDPS structure also contains a ''druggable'' allosteric cleft that binds the natural inhibitor, lysine. This mediates a canonical feedback inhibition response as depicted in Figure 1 . Lysine is a potent inhibitor of bacterial DHDPS, with IC 50 values ranging from 53 mM to 1 mM (Bakhiet et al., 1984; Devenish et al., 2009; Joerger et al., 2003; Laber et al., 1992; Skovpen and Palmer, 2013; Soares da Costa et al., 2010; Tam et al., 2004; Yugari and Gilvarg, 1965) , providing scope to incorporate rational drug design efforts to afford the discovery of high-affinity allosteric inhibitors (Skovpen et al., 2016) . In the allosteric binding site, two lysine molecules bind in a bis conformation in close proximity (Ca atoms $4 Å apart), with the side-chain 3-amino groups projecting away from each other . The bound lysine molecules are stabilized via a number of hydrogen bonding interactions mediated primarily by Ser48, Ala49, Leu51, His53, His56, Asn80, Glu84, and Tyr106 (Escherichia coli DHDPS numbering) ). The precise nature of lysine-mediated inhibition is not fully understood, and the same mechanism may not be shared by all lysine-inhibited DHDPS enzymes. Previous studies suggest that lysine binding changes the position of Tyr106 (E. coli numbering), which disrupts the hydrogen bonding network involving the general acid-base Tyr107 (E. coli numbering) and triggers changes in conformational flexibility of substrate-binding active-site residues (Atkinson et al., 2013; Dobson et al., 2005b) . Surprisingly, not all bacterial DHDPS enzymes are allosterically inhibited by lysine (Dogovski et al., 2009 (Dogovski et al., , 2012 Soares da Costa et al., 2015) , with both dimeric and tetrameric forms allosterically inhibited in some bacterial species but not in others (Burgess et al., 2008a; Dobson et al., 2005a; Kaur et al., 2011; Voss et al., 2010) . This demonstrates that oligomerization plays no role in allostery. Indeed, the current dogma suggests that DHDPS from Gram-negative bacteria are inhibited by lysine (Bakhiet et al., 1984; Devenish et al., 2009; Dobson et al., 2005b; Joerger et al., 2003; Kaur et al., 2011; Laber et al., 1992; Skovpen and Palmer, 2013; Soares da Costa et al., 2010; Tam et al., 2004; Yugari and Gilvarg, 1965) ; whereas the enzymes from Gram-positive bacteria are insensitive to allosteric regulation (Burgess et al., 2008a; Cahyanto et al., 2006; Cremer et al., 1988; Domigan et al., 2009; Halling and Stahly, 1976; Voss et al., 2010; Webster and Lechowich, 1970; Yamakura et al., 1974) . The lack of lysine sensitivity in Gram-positive bacteria has been attributed to the high lysine content of their cell walls (Slade and Slamp, 1962 ).
Here we initially set out to compare the structure and function of DHDPS from two common pneumonia-causing pathogens, namely the Gram-negative bacterium Legionella pneumophila (Lp) and the Gram-positive bacterium, Streptococcus pneumoniae (Sp). Strikingly, we show that SpDHDPS is the first example of a DHDPS from a Gram-positive pathogen that is allosterically inhibited by lysine. Conversely, we demonstrate that the ortholog from L. pneumophila is the first DHDPS from a Gram-negative pathogen that lacks allosteric inhibition. This prompted a reevaluation of the dogma and the identification of the molecular determinants that define lysine-mediated allosteric inhibition of DHDPS. As proof of concept, a selection of Gram-negative (Burkholderia pseudomallei and Coxiella burnetii) and Gram-positive (Enterobacter faecalis and Campylobacter sp. 17-4) DHDPS enzymes that were predicted to be sensitive and insensitive to lysine inhibition based on the newly identified determinants were examined. Our predictions were confirmed by employing a combination of bioinformatics, mutagenesis, protein biochemistry, biophysics, and enzymology. Thus we are now able to reliably predict the presence or absence of lysine-mediated inhibition of bacterial DHDPS.
RESULTS

Expression, Purification, and Primary Structure Analysis of LpDHDPS and SpDHDPS
The dapA gene encoding DHDPS was amplified from genomic DNA isolated from L. pneumophila and S. pneumoniae and cloned into the pET11a expression vector, and the recombinant DHDPS enzymes were overexpressed in E. coli and purified to >98% homogeneity as described in Experimental Procedures (Tables 1 and 2 ).
Solution Properties of LpDHDPS and SpDHDPS
Having confirmed the identity of recombinant LpDHDPS and SpDHDPS, we assessed the secondary structure of the proteins using circular dichroism (CD) spectroscopy. The CD spectra of the recombinant enzymes show broad double minima spanning 210-225 nm, which is consistent with the (b/a) 8 or TIM-barrel topology reported for DHDPS enzymes from different species (Atkinson et al., 2014; Blickling et al., 1997; Burgess et al., 2008a; Dogovski et al., 2013; Griffin et al., 2008 Griffin et al., , 2012 Mirwaldt et al., 1995; Voss et al., 2010) (Figure S1 ). To compare the quaternary Figure S2A ). This value compares well with the 4.2 S observed for the Staphylococcus aureus (Sa) DHDPS dimer (Burgess et al., 2008a) . Conversion of the c(s) profile to a c(M) distribution reveals an apparent molar mass of 61.4 kDa, consistent with the theoretical mass of an LpDHDPS dimer. In comparison, SpDHDPS (M r = 33,780.54) sediments as 7.4 S with a molecular mass of 131 kDa, consistent with a tetramer as previously described ) ( Figure S2B ). We were therefore interested in comparing the catalytic function of the LpDHDPS dimer and SpDHDPS tetramer.
Functional Comparison of LpDHDPS and SpDHDPS
Enzyme kinetics were performed in the absence and presence of (S)-lysine using the quantitative DHDPS-DHDPR coupled assay . Regarding SpDHDPS, the resulting kinetic analysis of LpDHDPS in the absence of lysine demonstrates that the enzyme catalyzes the condensation of (S)-ASA and pyruvate via a typical bibi ping-pong mechanism with no substrate inhibition (Table 3 ). However, in the presence of increasing concentrations of (S)-lysine, LpDHDPS surprisingly maintains 100% catalytic activity even up to the non-physiological concentration of 5 mM ( Figure 2A ). This is the first DHDPS enzyme from a Gram-negative pathogen to show a lack of lysine feedback inhibition. By contrast, the Gram-negative control, E. coli (Ec) DHDPS, is inhibited by lysine with an IC 50 of 0.18 mM (R 2 = 0.988), agreeing with previously published data (Soares da Costa et al., 2010) ( Figure 2A ). Even more striking is the observation that SpDHDPS is inhibited by lysine, which is the first case of lysine feedback inhibition reported for a Grampositive bacterium (Table 3 , Figure 2B ). For comparison, the activity of DHDPS from the Gram-positive control, S. aureus, shows no dose response ( Figure 2B ). Subsequent in-depth kinetic analyses showed that the mechanism of inhibition for SpDHDPS is mixed with respect to both substrates, resulting in inhibition constants (K i ) for (S)-ASA of K ic = 0.031 mM and K iu = 0.026 mM; and for pyruvate of K ic = 0.054 mM and K iu = 0.012 mM ( Figure S3 ). This demonstrates that the inhibition of SpDHDPS by lysine is at least 3-fold more potent compared with EcDHDPS (Ghislain et al., 1990; Karsten, 1997; Soares da Costa et al., 2010) . Given these surprising results, we were interested in determining and comparing the high-resolution crystal structures of apo (i.e., unliganded) LpDHDPS and SpDHDPS bound to lysine.
Crystal Structure Determination
To provide insight into the structural determinants that define the presence or absence of lysine-mediated allosteric inhibition of DHDPS, we determined the crystal structures of apo LpDHDPS (PDB: 4NQ1) and lysine-bound SpDHDPS (PDB: 4FHA) to 1.65-Å and 1.88-Å resolution, respectively, using the molecular replacement method. The data collection, processing, scaling, and refinement statistics are presented in Table 4 . The overall sequence identity between the two orthologs is 36% and the root-mean-square deviation (rmsd) over 290 residues between the structures is 1.6 Å . Consistent with our analytical ultracentrifuge data showing that LpDHDPS exists as a dimer in solution, two molecules of LpDHDPS are observed in the asymmetric unit ( Figure 3A ), as the canonical DHDPS dimer. The extensive interface comprises a total of 17 hydrogen bonds and a buried interface area of 1,418 Å 2 . Comparison of the LpDHDPS and EcDHDPS demonstrates a high degree of conservation in the spatial orientation of almost all active-site residues ( Figure S4 ). The exception is Tyr106, which shows $90 rotation relative to its E. coli counterpart, an effect also observed for the dimeric SaDHDPS (Burgess et al., 2008a; Girish et al., 2008) (PDB: 3DAQ and 3DI0). Shown in Figure 3B is an overlay of the L. pneumophila (green) and E. coli (purple) DHDPS allosteric sites. Depicted in orange is a lysine ligand bound to the E. coli site (PDB: 1YXD), which makes key contacts with His56, Tyr106, and Glu84. In LpDHDPS (PDB: 4NQ1) these residues are replaced with Lys55, Ala105, and Asp83, respectively. The side chain of Lys55 lies in close proximity to the 3-amino moiety of the bound lysine in the E. coli enzyme. This introduces potential electrostatic repulsion and steric hindrance that would prevent lysine binding into the LpDHDPS cleft. Furthermore, the carboxyl group of the lysine molecule is coordinated by the phenolic hydroxyl group of Tyr106 in EcDHDPS. A substitution to alanine eliminates this stabilizing interaction. Finally, Glu84 in EcDHDPS participates in a hydrogen bonding network with Ala49 and Asn80 to secure the The deconvoluted mass spectra reveal that the predominant peaks are consistent with the theoretical molecular mass for each protein. a-amino of the inhibitory lysine. An overlay of Asp83 and Glu84 reveals a significant rotation, as well as displacement, in their respective side chains ( Figure 3B ). Importantly, the side chain of Asp83 is orientated so that it cannot interact with either bound lysine or other allosteric site residues. The crystal structure of SpDHDPS in the presence of lysine (PDB: 4FHA) was next assessed. The lysine-bound enzyme forms a tetramer ( Figure 4A ), consistent with the apoenzyme , with one lysine bound per subunit (Figure 4B ). Similar to EcDHDPS, two molecules of lysine are observed bound in a bis conformation in the allosteric cleft formed at the dimer interface adjacent to the active site. However, unlike EcDHDPS, substantial conformational changes are observed when comparing the apo and lysine-bound structures, including significant rotations of His59 (His53, E. coli numbering) and Asp90 (Glu84, E. coli numbering). This results in significant movement, or ''tensing,'' of the two monomers closer together at the dimer interface, as well as an increase in the number of non-covalent interface contacts ( Figure 4B ). This may serve to decrease the accessibility of the substrates to the active site and/or the products from exiting. In addition, an electrostatic contact between bound lysine and Glu62 is observed in the SpDHDPS structure ( Figure 4B ), which is absent in the lysine-bound structure of EcDHDPS. Thus, the presence of this interaction may contribute to the tighter binding of lysine observed for SpDHDPS, consequently inhibiting catalysis.
Identification of the DHDPS Molecular Determinants
Defining Lysine Binding Given our surprising results demonstrating for the first time that lysine allosteric inhibition is not related to Gram staining as previously thought, we set out to characterize the structural determinants that define DHDPS-lysine interactions. Structural analyses comparing the sequence and chemical composition of allosteric site residues from DHDPS enzymes shown to be inhibited by lysine (e.g., PDB: 3M5V, 1YXD, 3FLU, and 4FHA) allowed the mapping of key residues that form interactions with the allosteric ligand. In E. coli (PDB: 1YXD), 16 residues (eight from each subunit) surround the two lysine molecules bound in the allosteric cleft, namely Ser48, Ala49, Leu51, His53, His56, Asn80, Glu84, and Tyr106. These residues form a series of hydrogen bonds either directly with the bound ligand or via coupled networks with the side-chain or backbone moieties of nearby residues. When compared with allosteric DHDPS enzymes from other Gram-negative species, it is noted that the ortholog from Campylobacter jejuni (PDB: 3M5V) has an allosteric site identical to that of the E. coli DHDPS, whereas the enzyme from Neisseria meningitidis (PDB: 3FLU) differs only at a single position, with Val replacing His53 ( Figure S5 ). By contrast, there are some notable differences in the allosteric site of DHDPS from the Gram-positive lysine-sensitive SpDHDPS, with Pro, Glu, and Asp replacing Ala49, His56, and Glu84. Despite these differences, a similar hydrogen bonding network is formed between the allosteric site residues and the ligand in S. pneumoniae and E. coli DHDPS enzymes. Interestingly, comparison of DHDPS protein sequences from species known to be insensitive to lysine allostery (Bacillus anthracis, Clostridium botulinum, L. pneumophila, and S. aureus) shows good conservation in the allosteric cleft, except for position 56 (E. coli numbering), which is a basic (i.e., Lys) residue ( Figure S5 ). We therefore hypothesize that DHDPS sequences containing His or Glu at position 56 will be allosterically inhibited by lysine, whereas those containing a basic (i.e., Lys or Arg) residue at this position will be insensitive to lysine-mediated allostery.
Testing the Newly Identified Determinant of Lysine Binding A multiple sequence alignment of uncharacterized DHDPS sequences from the Gram-negative intracellular pathogen B. pseudomallei and the Gram-positive bacterium E. faecalis shows that these sequences contain a histidine and a glutamate at position 56, respectively, suggesting that these enzymes will be sensitive to lysine-mediated allostery ( Figure 5 ). In comparison, the DHDPS sequences from the Gram-negative intracellular pathogen C. burnetii, and the Gram-positive species Campylobacter sp. 17-4, show that these orthologs contain a basic residue (Lys or Arg) at position 56, suggesting these enzymes will be insensitive to lysine inhibition ( Figure 5 ). Recombinant B. pseudomallei, E. faecalis, C. burnetii, and Campylobacter sp. 17-4 DHDPS enzymes were overexpressed in E. coli, purified, and characterized kinetically for lysine inhibition, as described in Experimental Procedures, to confirm these predictions. Lysine inhibition was initially examined using the qualitative o-aminobenzaldehyde assay (Mitsakos et al., 2011; Yugari and Gilvarg, 1965) , which assesses DHDPS activity based upon the formation of a purple chromophore.
As hypothesized, DHDPS from Gram-negative B. pseudomallei (BpDHDPS) and Gram-positive E. faecalis (EfDHDPS) are shown to be inhibited by lysine, whereas the orthologs from Gram-negative C. burnetii (CbDHDPS) and Gram-positive Campylobacter sp. 17-4 (CsDHDPS) are insensitive to lysine-mediated allostery ( Figure 6A ). These data were validated quantitatively using the coupled DHDPS-DHDPR assay to determine the IC 50 values for lysine of 120 mM (R 2 = 0.9931) and 172 mM (R 2 = 0.9939) for
BpDHDPS and EfDHDPS, respectively ( Figure 6B ).
Validation of the Lysine Binding Determinants
To confirm that the nature of the residue at position 56 dictates lysine binding and inhibition, we mutated the naturally occurring glutamate at position 56 in EfDHDPS to a lysine (EfDHDPS-E56K). The mutant enzyme was expressed and purified as described for the wild-type enzyme (see Experimental Procedures). Lysine binding was then compared for the wild-type and mutant enzymes using microscale thermophoresis (Wienken et al., 2010) . The K D for EfDHDPS was determined to be 148 ± 10 mM, which agrees well with the IC 50 value of 172 mM reported earlier. On the other hand, the mutant enzyme was unable to bind lysine even at 10 mM concentration ( Figure 7A ). The thermodynamic results for the mutant were confirmed kinetically using the coupled assay, indicating that, although catalytically active, EfDHDPS-E56K had become insensitive to lysine-mediated inhibition ( Figure 7B ).
DISCUSSION
We show in this study that DHDPS from the Gram-negative pathogen L. pneumophila and the Gram-positive bacterium S. pneumoniae do not conform to the current dogma for lysine inhibition. The underlying molecular basis for the lack of allostery in L. pneumophila was investigated by determining the crystal structure of the enzyme. Inspection of the allosteric pocket confirmed the absence of three key residues; His56, Tyr106, and Glu84 (E. coli numbering). Lysine-bound structures in the PDB have demonstrated the importance of these residues in binding and stabilizing lysine within the allosteric cleft. An overlay of the DHDPS allosteric sites in L. pneumophila and E. coli showed that residues involved in interacting with lysine were replaced with those that would either hinder the binding or fail to form the necessary contacts. Moreover, there are no compensating residues, and the putative allosteric site in LpDHDPS is significantly more open than the equivalent site in orthologs that bind lysine. On the other hand, SpDHDPS is the first DHDPS from a Grampositive bacterium to be shown to be inhibited by the end product of the lysine biosynthetic pathway. Furthermore, quantitative inhibition assays demonstrate that SpDHDPS exhibits a high degree of sensitivity to the inhibitory effects of (S)-lysine when compared with EcDHDPS (Dobson et al., 2004) . The structure of SpDHDPS co-crystallized with (S)-lysine reveals a marked conformational change including a large shift in the orientation of His59 (SpDHDPS numbering). These conformational changes are not evident for EcDHDPS in the presence of (S)-lysine compared with the apo structure. The additional electrostatic contact between (S)-lysine and Glu62 observed in the (S)-lysine-bound SpDHDPS structure may contribute to the tighter binding.
In this study, a key position that defines whether a bacterial DHDPS will allosterically bind lysine was identified. A multiple DHDPS sequence alignment highlights a distinction in the nature of the residue at position 56 that we propose is the major determinant for lysine inhibition of DHDPS. We predict that the presence of a histidine or glutamate at position 56 imbues allosteric inhibition, whereas the presence of a basic residue results in no inhibition. Characterization of BpDHDPS, CbDHDPS, CsDHDPS, and EfDHDPS in terms of lysine binding confirms our hypothesis proposed here. In addition, mutation of the glutamate at position 56 in EfDHDPS to a lysine completely abolished allosteric inhibition as assessed kinetically using the coupled assay and thermodynamically employing microscale thermophoresis, further validating our findings. We have therefore identified and validated a key position that defines allosteric inhibition in DHDPS from different bacterial species, providing insights into the molecular evolution of enzyme allostery. The findings in this study also provide insight into the targeted design of allosteric inhibitors of DHDPS. However, the reason why some DHDPS enzymes have evolved to be allosterically inhibited by lysine remains to be understood. It may be that a bacterium's environment and life cycle dictate the propensity for regulation by lysine. Regulation at the gene level may also provide sufficient control of this enzyme such that inhibition at the allosteric level is unnecessary. This remains to be explored in future studies.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of DHDPS Genomic DNA from L. pneumophila (strain Alcoy) and a clinical isolate of S. pneumoniae (serotype 3) were used in this study. The procedures for amplifying and cloning the dapA gene (encoding DHDPS) from L. pneumophila and S. pneumoniae and for the overexpression and purification of recombinant DHDPS were performed as described previously (Atkinson et al., 2011; Burgess et al., 2008b; Dogovski et al., 2013; Sibarani et al., 2010; Siddiqui et al., 2013) . Briefly, dapA encoding DHDPS was PCR-amplified from genomic DNA and cloned into pET11a, pET28a, or pRSET A expression vector (Table 1) . The EfDHDPS-E56K mutant was commercially synthesized by Bioneer and subcloned into the expression vector pET28a. Recombinant protein was produced in E. coli BL21-DE3 cells upon induction with 1 mM isopropyl b-D-1-thiogalactopyranoside in Luria broth at 37 C or 16 C (L. pneumophila DHDPS).
Cells were harvested by centrifugation and sonicated in 20 mM Tris (pH 8.0). Chromatography purification techniques were employed to yield >98% pure recombinant protein (Table 3) . Electrospray ionization time-of-flight mass spectrometry confirmed the identity of the recombinant product (Table 2) .
Circular Dichroism Spectroscopy CD spectroscopy was performed using 1-mm quartz cuvettes in the Aviv Model 420 CD spectrometer as previously described (Atkinson et al., 2014; Burgess et al., 2008a; Dogovski et al., 2013; Griffin et al., 2008 Griffin et al., , 2012 Voss et al., 2010) . In brief, wavelength scans were conducted between 200 and 240 nm in 0.5-nm increments with 2-s averaging time at 20 C. Protein samples were prepared in 20 mM Tris and 150 mM NaCl (pH 8.0) at 150 mg ml 
Analytical Ultracentrifugation
Sedimentation velocity experiments were conducted in a model XL-A analytical ultracentrifuge (Beckman Coulter) using similar methods described previously (Atkinson et al., 2014; Burgess et al., 2008a; Dogovski et al., 2013; Griffin et al., 2008 Griffin et al., , 2012 Voss et al., 2010) . Cells were loaded with 400 ml of reference buffer and 380 ml of DHDPS at a concentration of 150 mg ml À1 into doublesector quartz cells equipped with charcoal-Epon centerpieces within a fourhole An60 Ti or eight-hole An50 Ti rotor. Data were collected at a wavelength of 280 nm, temperature of 20 C, and rotor speed of 40,000 rpm in continuous mode employing a step size of 0.003 cm without averaging. Data at multiple time points were fitted to a continuous mass or sedimentation coefficient distribution model using SEDFIT software (Schuck, 2000; Schuck et al., 2002) . SEDNTERP (Laue et al., 1992 ) was used to estimate solvent density, solvent viscosity, and the partial specific volume of DHDPS for analysis. Standardized weight-average sedimentation coefficients (s 20,w ) were also calculated in SEDNTERP (Laue et al., 1992) .
Enzyme Kinetics
For quantitative analysis of DHDPS enzymatic activity, this study employed a coupled assay as described previously (Atkinson et al., 2014; Burgess et al., 2008b; Dobson et al., 2005b; Dogovski et al., 2013; Sequence alignment of the allosteric site residues in DHDPS from Gram-positive (purple) and Gramnegative (red) bacteria, including those characterized in this study. Numbering shown is for E. coli DHDPS. See also Figure S5 . Voss et al., 2010) . Substrate turnover was measured spectrophotometrically at A 340 nm ( 3 340 nm = 6,220 M À1 cm À1 ) via the associated oxidation of NADPH. Assays were prepared in triplicate, incubated for 5 min at 30 C in a temperature-controlled Cary 4000 UV/Vis spectrophotometer (Varian), and initiated with the substrate (S)-ASA. Initial velocities were determined from the initial linear portion of the reaction coordinate and averaged across triplicate measurements. Initial velocity data were analyzed using ENZFITTER (Biosoft) and fitted to the ping-pong mechanism using Equation 1:
where V max is the maximal velocity, K M(A) and K M(B) are the Michaelis-Menten constants for each substrate, A and B are the substrate concentrations, and v is the initial velocity. To test for inhibition by lysine, we incubated all assay components except (S)-ASA and lysine in a cuvette for 5 min as described above. This was followed by addition of lysine (final concentration range 0-5 mM) and a further 5-min incubation. Reactions were initiated with (S)-ASA and rates were recorded as described above. Data were fitted using Sigma Plot version 13.0.
o-Aminobenzaldehyde Assay
The o-aminobenzaldehyde (o-ABA) colorimetric activity assay (Yugari and Gilvarg, 1965 ) was used to qualitatively determine DHDPS activity. Assays were performed in 96-well plates with the addition of 100 ml of master mix solution (200 mM Tris [pH 6.8], 30 mM pyruvate, 10 mM o-ABA, and 5 mM (S)-ASA) in the presence or absence of 5 mM (S)-lysine. Appropriate controls of no enzyme and no substrate were also included. Reactions were initiated with 5 mM of protein sample and incubated at 37 C for 20 min. Reactions were terminated by the addition of 100 ml of trichloroacetic acid (10% [v/v] ). In the presence of DHDPS activity a purple chromophore was observed, while in its absence a pale yellow color was noted (Mitsakos et al., 2008) .
Microscale Thermophoresis
Affinity measurements using microscale thermophoresis (MST) were carried out with a Monolith NT.LabelFree instrument (NanoTemper Technologies). Lysine diluted in water (20 mM to 2.44 mM) was mixed 1:1 with the enzyme, yielding a final DHDPS concentration of 3 mM and a dilution series of 10 mM to 1.22 mM for lysine. All experiments were incubated for 30 min at 30 C, before applying samples to Monolith NT Standard Treated Capillaries (NanoTemper Technologies). Thermophoresis was measured at 30 C with laser off/on/off times of 5 s/30 s/5 s. Experiments were conducted at 20% LED power and 40% MST IR laser power. Data from three independently performed experiments were analyzed (NT.Analysis software version 1.5.41, NanoTemper Technologies) using the signal from Thermophoresis + T-Jump.
Crystallization, Structure Determination, and Refinement X-Ray diffraction experiments were carried out at the Australian Synchrotron on the MX1 beamline (Cowieson et al., 2015) using Blu-Ice (McPhillips et al., 2002) . LpDHDPS was crystallized using the hanging-drop vapor diffusion method as previously described (Siddiqui et al., 2013) . Crystals were soaked in reservoir solution containing 20% (v/v) 2-methyl-2,4-pentanediol (MPD) prior to data collection. Indexing and integration of the diffraction data were performed using iMOSFLM (Battye et al., 2011) scaling using SCALA (Evans, 2006) . The crystal was found to belong to space group P6 1 22. The Matthews coefficient of 2.64 Å 3 Da À1 with an estimated solvent content of 53.5% indicated that there were two monomers in the asymmetric unit. Molecular replacement was performed using PHASER (McCoy et al., 2007) with a single chain of Pseudomonas aeruginosa DHDPS as the search model (PDB: 3QZE; 54% sequence identity). Iterative model building of the structure and refinement was performed in WINCOOT (Emsley and Cowtan, 2004) and REFMAC5 (Murshudov et al., 1997; Winn et al., 2011) , respectively. A lysine bonded to pyruvate as a Schiff base was built in sketcher from the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) . This modified lysine was used to replace Lys160 in the model and fitted to the 2F o À F c electron density. The MPD molecules were also built in sketcher. Babinet scaling in REFMAC5 was applied in the final rounds of refinement. Structure quality was assessed by MolProbity and WINCOOT (Chen et al., 2010; Davis et al., 2007) . SpDHDPS was co-crystallized with (S)-lysine using the hanging-drop vapor diffusion method as previously described Sibarani et al., 2010) , with (S)-lysine added to the protein solution in a 1:1 ratio (1 ml of concentrated (S)-lysine at 1 M added to 1 ml of concentrated protein solution at 8 mg ml À1 ). Crystals were soaked in reservoir solution containing 0.2 M sodium fluoride, 20% (w/v) polyethylene glycol 3350, 0.1 M bis-Tris propane (pH 6.0), and 15% (w/v) glycerol prior to data collection at 100 K. A 97.8% complete dataset was integrated to 1.88-Å resolution using XDS (Kabsch, 2010) and scaled using SCALA (Evans, 2006) . Data analysis using phenix.xtriage (Zwart et al., 2005) revealed the presence of pseudo-merohedral twinning, which resulted in a space-group change from P4 2 2 1 2 to P2 1 2 1 2 with a = 106.37 Å , b = 106.23 Å , and c = 60.38 Å , similar to the parent unliganded structure of SpDHDPS . Molecular replacement was carried out using the program PHASER (McCoy et al., 2007) with the structure of the native form of SpDHDPS (PDB: 3VFL), using the most complete monomer as the search model, which packed one molecule in the asymmetric unit. The structure was refined using REFMAC5 (Murshudov et al., 1997; Winn et al., 2011) , including TLS refinement (Winn et al., 2003) . Iterative model building was carried out using the program Coot (Emsley and Cowtan, 2004) .
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